Wednesday, October 6, 2021
6:00PM – 7:00PM ET
Please note this TeleECHO program is 6:00PM Eastern, 5:00PM Central, 4:00PM Mountain and 3:00PM Pacific.
PROGRAM OVERVIEW
This live virtual TeleECHO program will explore the management of small cell lung cancer (SCLC) in the second-line setting. A brief didactic presentation will discuss treatment options after relapse of SCLC and clinical trial data of the efficacy and safety of second-line treatment regimens. Interactive case studies will illustrate the application of guideline recommendations for treatments approved for managing extensive-stage SCLC.
Presenting Faculty:
Julia Rotow, MD
Thoracic Oncologist
Dana-Faber Cancer Institute
Medical Oncologist
Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
Boston, MA
LEARNING OBJECTIVES
After completing the CME activity, learners should be better able to:
- Review the efficacy and safety data of systemic regimens in the second-line treatment of patients with extensive-stage SCLC
- Discuss the clinical trial data supporting the NCCN guidelines in the second-line treatment of patients with extensive-stage SCLC
- Describe how to apply the second-line efficacy and safety data to the management of small-cell lung cancer in the patient care setting
TARGET AUDIENCE
This activity is intended for community-based oncologists, pulmonologists, oncology nurses, nurse practitioners and other healthcare professionals who treat patients with small cell lung cancer.
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This virtual CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtual activity for a maximum of 1.0 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSING CREDIT INFORMATION
Purpose: This virtual program would be beneficial for nurses involved in the management of patients with SCLC in the second-line setting. CNE Credits: 1.0 ANCC Contact Hour.
CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
ABIM Maintenance of Certification
Successful completion of this virtual CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at [email protected].
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
